搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Escherichia coli O17:K52:H18 DNA ligase B (ligB) CSB-YP485466EOG
CSB-EP485466EOG
CSB-BP485466EOG
CSB-MP485466EOG
CSB-EP485466EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 D-galactonate dehydratase (dgoD) CSB-YP485467EOG
CSB-EP485467EOG
CSB-BP485467EOG
CSB-MP485467EOG
CSB-EP485467EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 tRNA modification GTPase MnmE (mnmE) CSB-YP485468EOG
CSB-EP485468EOG
CSB-BP485468EOG
CSB-MP485468EOG
CSB-EP485468EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 ATP synthase gamma chain (atpG) CSB-YP485469EOG
CSB-EP485469EOG
CSB-BP485469EOG
CSB-MP485469EOG
CSB-EP485469EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Aspartate--ammonia ligase (asnA) CSB-YP485470EOG
CSB-EP485470EOG
CSB-BP485470EOG
CSB-MP485470EOG
CSB-EP485470EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Guanosine-5'-triphosphate,3'-diphosphate pyrophosphatase (gppA) CSB-YP485471EOG
CSB-EP485471EOG
CSB-BP485471EOG
CSB-MP485471EOG
CSB-EP485471EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Diaminopimelate epimerase (dapF) CSB-YP485472EOG
CSB-EP485472EOG
CSB-BP485472EOG
CSB-MP485472EOG
CSB-EP485472EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Der GTPase-activating protein YihI (yihI) CSB-YP485473EOG
CSB-EP485473EOG
CSB-BP485473EOG
CSB-MP485473EOG
CSB-EP485473EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Rhamnulose-1-phosphate aldolase (rhaD) CSB-YP485474EOG
CSB-EP485474EOG
CSB-BP485474EOG
CSB-MP485474EOG
CSB-EP485474EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 CDP-diacylglycerol pyrophosphatase (cdh), partial CSB-YP485475EOG
CSB-EP485475EOG
CSB-BP485475EOG
CSB-MP485475EOG
CSB-EP485475EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 ATP-dependent protease subunit HslV (hslV) CSB-YP485476EOG
CSB-EP485476EOG
CSB-BP485476EOG
CSB-MP485476EOG
CSB-EP485476EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Pantothenate kinase (coaA) CSB-YP485477EOG
CSB-EP485477EOG
CSB-BP485477EOG
CSB-MP485477EOG
CSB-EP485477EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Phosphomethylpyrimidine synthase (thiC) CSB-YP485478EOG
CSB-EP485478EOG
CSB-BP485478EOG
CSB-MP485478EOG
CSB-EP485478EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Homoserine O-succinyltransferase (metA) CSB-YP485479EOG
CSB-EP485479EOG
CSB-BP485479EOG
CSB-MP485479EOG
CSB-EP485479EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Glycerol-3-phosphate acyltransferase (plsB), partial CSB-YP485480EOG
CSB-EP485480EOG
CSB-BP485480EOG
CSB-MP485480EOG
CSB-EP485480EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Fumarate reductase subunit D (frdD), partial CSB-YP485481EOG1
CSB-EP485481EOG1
CSB-BP485481EOG1
CSB-MP485481EOG1
CSB-EP485481EOG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Protein hfq (hfq) CSB-YP485482EOG
CSB-EP485482EOG
CSB-BP485482EOG
CSB-MP485482EOG
CSB-EP485482EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 L-ribulose-5-phosphate 3-epimerase UlaE (ulaE) CSB-YP485483EOG
CSB-EP485483EOG
CSB-BP485483EOG
CSB-MP485483EOG
CSB-EP485483EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Iron-sulfur cluster repair protein YtfE (ytfE) CSB-YP485484EOG
CSB-EP485484EOG
CSB-BP485484EOG
CSB-MP485484EOG
CSB-EP485484EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Primosomal protein 1 (dnaT) CSB-YP485485EOG
CSB-EP485485EOG
CSB-BP485485EOG
CSB-MP485485EOG
CSB-EP485485EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>